Decreased heart rate variability in patients with psoriatic arthritis

Clinical Rheumatology

Volumn 31, Issue 9, 2012, Pages 1377-1381

  Gaydukova, Inna ^a   Rebrov, Andrey ^a   Nikitina, Natalia ^a   Poddubnyy, Denis ^b  

^a SARATOV STATE MEDICAL UNIVERSITY   (Russian Federation)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Heart rate variability; Inflammation; Psoriatic Arthritis

Indexed keywords

CHOLESTEROL;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE DURATION; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART RATE VARIABILITY; HUMAN; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REST; RR INTERVAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RISK; RISK FACTORS; TREATMENT OUTCOME;

EID: 84867880355     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-2015-3     Document Type: Article

References (33)

1. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE (2000) The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 27(5):1247-1250 (Pubitemid 30262512)
2. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53(4):573
3. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61(2):233-239
4. Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41(6):1103-1110. doi:10.1002/1529- 0131(199806)41:6<1103::AIDART18> 3.0.CO;2-N (Pubitemid 28265412)
5. Wong K, Gladman DD, Husted J, Long JA, Farewell VT (1997) Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 40 (10):1868-1872. doi:10.1002/1529-0131(199710)40:10<1868:: AID-ART21>3.0.CO;2-W (Pubitemid 27452539)
6. Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT (2009) Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 68(7):1131-1135. doi:10.1136/ard.2008.094839
7. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33(11):2167-2172 (Pubitemid 44749774)
8. Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, Bitterman H, Feld J, Rimar D, Rosner I (2008) Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35 (5):877-882 (Pubitemid 351747131)
9. Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, Ohman ML, Rantapaa-Dahlqvist S, Wallberg-Jonsson S (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 13(4):R131. doi:10.1186/ar3442
10. Bengtsson C, Ohman ML, Nived O, Rantapaa Dahlqvist S (2011) Cardiovascular event in systemic lupus erythematosus in northern Sweden - incidence and predictors in a 7-year follow up study. Lupus. doi:10.1177/0961203311425524
11. Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J (2011) Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 27(2):174-182. doi:10.1016/j.cjca.2010.12.040
12. Khan F, Galarraga B, Belch JJ (2010) The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 6(5):253-261. doi:10.1038/nrrheum.2010.44
13. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF (2004) Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25 (5):363-370 (Pubitemid 38391517)
14. Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13(3-4):178-184 (Pubitemid 46944960)
15. Madsen T, Christensen JH, Toft E, Schmidt EB (2007) C-reactive protein is associated with heart rate variability. Ann Noninvasive Electrocardiol 12(3):216-222 (Pubitemid 47037950)
16. Lampert R, Bremner JD, Su S,Miller A, Lee F, Cheema F, Goldberg J, Vaccarino V (2008) Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 156(4):759, e751-757
17. de Bruyne MC, Kors JA, Hoes AW, Klootwijk P, Dekker JM, Hofman A, van Bemmel JH, Grobbee DE (1999) Both decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: the Rotterdam Study. Am J Epidemiol 150(12):1282-1288
18. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG (2000) Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 102(11):1239-1244
19. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Hansen JF (2006) C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J Intern Med 260(4):377-387 (Pubitemid 44370911)
20. Evrengul H, Dursunoglu D, Cobankara V, Polat B, Seleci D, Kabukcu S, Kaftan A, Semiz E, Kilic M (2004) Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 24 (4):198-202. doi:10.1007/s00296-003-0357- 5 (Pubitemid 39062488)
21. Kaya EB, Okutucu S, Aksoy H, Karakulak UN, Tulumen E, Ozdemir O, Inanici F, Aytemir K, Kabakci G, Tokgozoglu L, Ozkutlu H, Oto A (2010) Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability. Clin Res Cardiol: Off J German Card Soc 99(12):803-808. doi:10.1007/s00392-010-0187-x
22. Poddubnyi DA, Gaidukova IZ, Rebrov AP (2009) Heart rate variability in patients with ankylosing spondilitis (Bekhterev's disease). Ter Arkh 81(6):56-62
23. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665-2673 (Pubitemid 44205029)
24. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R, van ver Tempel H, Mielants H, Dougados M, van der Heijde D (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127-132 (Pubitemid 36135387)
25. van der Heijde DM, van't Hof M, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20(3):579-581 (Pubitemid 23102498)
26. Poddubnyy DA, Rudwaleit M, Listing J, Braun J, Sieper J (2010) Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis 69(7):1338-1341
27. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359(9313):1173-1177. doi:10.1016/S0140-6736(02)08213-2 (Pubitemid 34304256)
28. van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8(5):R151. doi:10.1186/ar2045
29. Carmona L, Descalzo MA, Perez-Pampin E, Ruiz-Montesinos D, Erra A, Cobo T, Gomez-Reino JJ (2007) All-cause and causespecific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Ann Rheum Dis 66(7):880-885. doi:10.1136/ard.2006.067660 (Pubitemid 46999787)
30. DixonWG, Watson KD, Lunt M, Hyrich KL, Silman AJ, Symmons DP (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56(9):2905-2912. doi:10.1002/art.22809 (Pubitemid 47502736)
31. Da Silva JA, Jacobs JW, Kirwan JR, Boers M, Saag KG, Ines LB, de Koning EJ, Buttgereit F, Cutolo M, Capell H, Rau R, Bijlsma JW (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 65(3):285-293. doi:10.1136/ard.2005.038638 (Pubitemid 43268214)
32. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325-331. doi:10.1136/ard.2009.113696
33. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332 (7553):1302-1308. doi:10.1136/bmj.332.7553.1302